Mark Uhlik
Mark is a seasoned leader in translational oncology and drug discovery/development with over 15 years of experience in the pharmaceutical industry. Mark earned his B.S. in Microbiology from Colorado State University and his Ph.D. in Microbiology and Immunology at Pennsylvania State University College of Medicine. He performed post-doctoral work at University of Colorado Health Sciences Center and at University of North Carolina School of Medicine. Mark has authored over 35 peer-reviewed publications in addition to book chapters and patents.